Case File №
#VI-2026-0550
Paramount Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | A Great | 7 | 8.2 | 6.5 | 9.5 | 27 Feb 2025 |
| PT-141 | C Okay | 3 | 8.0 | 4.7 | 9.8 | 25 Apr 2025 |
| Semaglutide | C Okay | 9 | 6.3 | 4.6 | 8.9 | 14 Jan 2025 |
| Retatrutide | C Okay | 12 | 7.5 | 4.3 | 9.3 | 14 Jan 2025 |
| Survodutide | C Okay | 3 | 5.2 | 4.6 | 6.0 | 25 Apr 2025 |
| BPC-157 | D Poor | 11 | 6.8 | 3.2 | 9.0 | 14 Jan 2025 |
| Tirzepatide | D Poor | 11 | 6.8 | 3.6 | 8.9 | 14 Jan 2025 |
| CJC-1295 | E Bad | 9 | 4.9 | 2.2 | 6.8 | 14 Jan 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 6 | 7.2 | 4.3 | 9.4 | 23 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 6 | 6.5 | 3.6 | 7.9 | 25 May 2026 |
| Adipotide | X N/A | 1 | 5.2 | 5.2 | 5.2 | 14 Jan 2025 |
| Alprostadil | X N/A | 1 | 6.9 | 6.9 | 6.9 | 6 May 2025 |
| APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | X N/A | 6 | 7.1 | 3.7 | 9.6 | 24 May 2026 |
| Boldenone Undecylenate (EQ) Raw | X N/A | 3 | 7.8 | 6.8 | 8.6 | 24 May 2026 |
| BPC 500mcg + TB500 500mcg Blend Oral | X N/A | 6 | 6.5 | 5.5 | 8.3 | 25 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 6 | 7.1 | 5.0 | 10.0 | 23 May 2026 |
| Cerebrolysin | X N/A | 6 | 6.0 | 5.4 | 7.7 | 24 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 2 | 6.5 | 6.2 | 6.7 | 24 May 2026 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 6.2 | 6.2 | 6.2 | 7 May 2025 |
| DNP | X N/A | 5 | 6.1 | 4.7 | 7.9 | 20 May 2026 |
| GHRP-2 Acetate | X N/A | 6 | 7.4 | 5.5 | 9.5 | 25 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 4 | 6.8 | 6.1 | 8.1 | 17 May 2026 |
| HGH 191AA (Somatropin) | X N/A | 5 | 6.4 | 5.3 | 7.4 | 20 May 2026 |
| Hyaluronic acid | X N/A | 5 | 6.3 | 3.8 | 8.0 | 21 May 2026 |
| IGF-1 LR3 | X N/A | 6 | 6.5 | 4.4 | 9.1 | 25 May 2026 |
| Ivermectin | X N/A | 6 | 6.4 | 4.6 | 8.4 | 21 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 2 | 5.4 | 4.6 | 6.3 | 21 May 2026 |
| KPV Oral | X N/A | 3 | 7.0 | 6.2 | 7.7 | 21 May 2026 |
| N-Acetyl Epitalon Amidate | X N/A | 6 | 5.9 | 3.5 | 8.0 | 25 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 2 | 7.2 | 4.5 | 10.0 | 20 May 2026 |
| Nandrolone Decanoate (Deca) Raw | X N/A | 1 | 6.4 | 6.4 | 6.4 | 3 Jun 2025 |
| NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | X N/A | 6 | 6.5 | 4.4 | 9.3 | 24 May 2026 |
| P21 | X N/A | 3 | 7.4 | 7.0 | 7.6 | 17 May 2026 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | X N/A | 6 | 6.9 | 5.4 | 8.4 | 24 May 2026 |
| Retatrutide Raw | X N/A | 3 | 7.1 | 4.1 | 10.0 | 21 May 2026 |
| Salbutamol | X N/A | 3 | 6.9 | 6.1 | 7.4 | 24 May 2026 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 6 | 7.3 | 4.8 | 9.0 | 24 May 2026 |
| Test Suspension | X N/A | 4 | 6.0 | 5.2 | 7.0 | 23 May 2026 |
| Vesugen | X N/A | 2 | 7.7 | 6.9 | 8.4 | 25 May 2026 |
| Vilon | X N/A | 3 | 6.8 | 6.4 | 7.5 | 21 May 2026 |
Exhibit II
Evidence Log
138 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 6.9 A | 100mg | 108.5mg | +8.5% | 97.01% | zgfew5 | Lab A | Public |
| 25 May 2026 | GHRP-2 Acetate | 6.9 A | 15mg | 17.4mg | +15.9% | 98.34% | 1dk1e7 | Lab D | Public |
| 25 May 2026 | Ivermectin | 6.2 A | 50mg | 46.2mg | -7.7% | 99.94% | srq9va | Lab A | Community |
| 25 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 5.4 B | 100g | 93.0g | -7.0% | 98.19% | 8588vt | Lab D | Public |
| 24 May 2026 | Adipotide | 7.1 A | 20mg | 20.8mg | +4.2% | 99.48% | toknod | Lab E | Public |
| 24 May 2026 | Cerebrolysin | 8.7 A | 15mg | 15.0mg | -0.2% | 98.02% | f1olg6 | Lab G | Public |
| 24 May 2026 | HGH 191AA (Somatropin) | 5.9 B | 50mg | 55.4mg | +10.8% | 97.50% | mqkck1 | Lab G | Public |
| 24 May 2026 | Vilon | 6.8 A | 5mg | 5.0mg | +0.6% | 97.83% | j0h3dt | Lab A | Community |
| 24 May 2026 | GHRP-2 Acetate | 8.6 A | 15mg | 17.0mg | +13.6% | 99.78% | 846kdt | Lab D | Public |
| 24 May 2026 | GHRP-2 Acetate | 6.6 A | 50mg | 48.5mg | -3.1% | 98.75% | dpwv0o | Lab F | Public |
| 24 May 2026 | 17a-Methyl-1-Testosterone | 8.6 A | 20mg | 20.2mg | +1.1% | 95.61% | nruc5l | Lab G | Public |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.2 A | 30mg | 35.8mg | +19.2% | 99.21% | d4lupm | Lab C | Public |
| 24 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 8.8 A | 500g | 590.4g | +18.1% | 99.84% | ujwqzg | Lab D | Public |
| 24 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 5.1 B | 10mg | 12.3mg | +22.9% | 98.02% | y9i3ny | Lab D | Public |
| 24 May 2026 | Cerebrolysin | 6.0 A | 10mg | 8.8mg | -12.4% | 96.46% | earvqr | Lab G | Community |
| 24 May 2026 | Ivermectin | 5.8 B | 25mg | 22.2mg | -11.2% | 99.34% | 11hgdk | Lab B | Community |
| 24 May 2026 | Salbutamol | 6.6 A | 50mg | 52.7mg | +5.3% | 98.67% | xzs83g | Lab G | Public |
| 24 May 2026 | Test Suspension | 6.4 A | 200mg/ml | 207.9mg/ml | +4.0% | 99.52% | 7a9f7d | Lab F | Public |
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 4.3 C | 5g | 5.4g | +8.2% | 96.69% | 2aexn6 | Lab G | Public |
| 24 May 2026 | KPV Oral | 6.9 A | 100mg | 96.6mg | -3.4% | 96.51% | 9vgm3w | Lab B | Public |
| 24 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 6.9 A | 500g | 541.5g | +8.3% | 98.26% | onxb0e | Lab D | Public |
| 24 May 2026 | Test Suspension | 5.3 B | 100mg/ml | 109.4mg/ml | +9.4% | 95.28% | lbpnwy | Lab D | Public |
| 24 May 2026 | Test Suspension | 4.5 C | 250mg/ml | 300.8mg/ml | +20.3% | 97.56% | hf97ev | Lab G | Public |
| 23 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 6.0 A | 500g | 568.7g | +13.7% | 97.83% | 8zn9s2 | Lab D | Community |
| 23 May 2026 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 7.7 A | 100g | 96.2g | -3.8% | 98.29% | f2fp5g | Lab B | Community |
| 23 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.6 A | 50mg | 45.4mg | -9.2% | 99.11% | ufrwhg | Lab E | Community |
| 23 May 2026 | GHRP-2 Acetate | 6.9 A | 50mg | 42.8mg | -14.3% | 96.88% | m10jkj | Lab G | Public |
| 23 May 2026 | Hyaluronic acid | 5.3 B | 20mg | 18.4mg | -8.0% | 99.67% | kdyox0 | Lab B | Community |
| 23 May 2026 | KPV Oral | 4.9 C | 50mg | 50.4mg | +0.9% | 99.25% | xnm1br | Lab E | Community |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.0 A | 10mg | 11.4mg | +14.5% | 99.79% | 3qawmk | Lab G | Public |
| 23 May 2026 | Hyaluronic acid | 5.1 B | 15mg | 15.3mg | +1.7% | 98.70% | qllkhk | Lab B | Community |
| 23 May 2026 | IGF-1 LR3 | 5.3 B | 15mg | 18.6mg | +24.3% | 96.82% | zqhqv2 | Lab F | Public |
| 23 May 2026 | N-Acetyl Epitalon Amidate | 4.8 C | 20mg | 20.2mg | +1.0% | 99.44% | a4v65f | Lab G | Public |
| 21 May 2026 | HGH 191AA (Somatropin) | 7.3 A | 15mg | 13.4mg | -10.8% | 97.16% | mju84f | Lab B | Public |
| 21 May 2026 | IGF-1 LR3 | 5.4 B | 5mg | 5.4mg | +8.1% | 96.58% | 4kk5r1 | Lab A | Community |
| 21 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 7.1 A | 5g | 5.7g | +14.6% | 97.02% | nq2ux2 | Lab A | Community |
| 21 May 2026 | 17a-Methyl-1-Testosterone | 5.8 B | 100mg | 95.3mg | -4.7% | 95.83% | kenaq4 | Lab A | Community |
| 21 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 7.7 A | 100g | 89.0g | -11.0% | 95.57% | 0fsdvf | Lab A | Public |
| 21 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.1 A | 5mg | 5.5mg | +9.1% | 98.66% | 4y1mnp | Lab E | Public |
| 21 May 2026 | IGF-1 LR3 | 5.8 B | 30mg | 25.9mg | -13.5% | 97.17% | utvtva | Lab A | Public |
| 21 May 2026 | Ivermectin | 7.2 A | 20mg | 18.2mg | -8.9% | 99.03% | n9a3va | Lab G | Community |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.7 B | 50mg | 53.6mg | +7.2% | 96.57% | nau18d | Lab A | Public |
| 21 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 6.1 A | 100g | 125.0g | +25.0% | 98.78% | bypq57 | Lab G | Public |
| 21 May 2026 | Salbutamol | 7.7 A | 50mg | 52.0mg | +4.0% | 98.58% | frv03z | Lab E | Community |
| 21 May 2026 | Test Suspension | 6.6 A | 100mg/ml | 118.6mg/ml | +18.6% | 98.41% | 1mh3mf | Lab D | Public |
| 20 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 6.7 A | 500g | 566.7g | +13.3% | 98.85% | dw32wi | Lab B | Community |
| 20 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.1 B | 10mg | 12.2mg | +21.6% | 97.07% | 5i3d72 | Lab G | Community |
| 20 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.3 A | 2mg | 1.8mg | -9.3% | 96.59% | 9cen1u | Lab C | Community |
| 20 May 2026 | Hyaluronic acid | 6.1 A | 10mg | 11.6mg | +15.7% | 97.31% | ip7lwn | Lab G | Public |
| 20 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.0 A | 20mg | 20.7mg | +3.5% | 99.56% | 03ktj7 | Lab F | Community |
| 19 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 5.2 B | 100mg | 124.8mg | +24.8% | 96.61% | kci87t | Lab F | Community |
| 19 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.8 A | 30mg | 27.1mg | -9.8% | 95.53% | bi77jb | Lab F | Community |
| 19 May 2026 | Cerebrolysin | 5.0 B | 20mg | 18.3mg | -8.6% | 96.06% | 4eb1ov | Lab E | Community |
| 19 May 2026 | DHB (1-Test Cyp) Oral | 6.4 A | 20mg | 24.1mg | +20.7% | 98.21% | xdfel9 | Lab D | Public |
| 19 May 2026 | Ivermectin | 8.1 A | 100mg | 110.9mg | +10.9% | 95.91% | aa95js | Lab G | Community |
| 17 May 2026 | Tirzepatide | 6.5 B | 20mg | 22.1mg | +10.5% | 99.08% | 01/2026 | Lab E | Public |
| 17 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 6.3 A | 500g | 606.1g | +21.2% | 98.13% | 1xvbq5 | Lab F | Public |
| 29 Jan 2026 | 17a-Methyl-1-Testosterone | 5.6 B | 50mg | 44.5mg | -11.1% | 97.65% | waif20 | Lab C | Public |
| 29 Jan 2026 | DNP | 5.8 B | 100mg | 95.3mg | -4.7% | 98.18% | va9vuj | Lab C | Public |
| 29 Jan 2026 | HGH 191AA (Somatropin) | 7.1 A | 10mg | 11.9mg | +19.0% | 97.70% | vpgbj3 | Lab B | Public |
| 29 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 5.2 B | 30mg | 26.6mg | -11.2% | 99.07% | y0was9 | Lab D | Public |
| 29 Jan 2026 | N-Acetyl Epitalon Amidate | 8.8 A | 50mg | 50.7mg | +1.4% | 95.80% | 6zlnbf | Lab F | Public |
| 29 Jan 2026 | N-Acetyl Epitalon Amidate | 5.5 B | 10mg | 10.1mg | +1.3% | 99.92% | j936qa | Lab F | Community |
| 29 Jan 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 7.5 A | 500g | 619.3g | +23.9% | 98.81% | ewrdop | Lab A | Community |
| 29 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 8.3 A | 50mg | 49.1mg | -1.8% | 95.15% | 80204w | Lab B | Community |
| 26 Jan 2026 | Boldenone Undecylenate (EQ) Raw | 8.6 A | 10g | 8.7g | -12.9% | 95.95% | itwwww | Lab A | Community |
| 26 Jan 2026 | Ivermectin | 6.4 A | 100mg | 105.3mg | +5.3% | 98.14% | 80gfbw | Lab C | Community |
| 26 Jan 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 5.8 B | 5g | 4.6g | -7.5% | 99.18% | ayngs4 | Lab D | Public |
| 19 Jan 2026 | DNP | 7.2 A | 10mg | 11.9mg | +18.8% | 95.24% | ifadb6 | Lab E | Community |
| 19 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.4 A | 30mg | 27.6mg | -8.0% | 96.67% | ojeo99 | Lab D | Community |
| 19 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.9 A | 50mg | 48.6mg | -2.7% | 99.94% | vzv27t | Lab D | Public |
| 9 Jan 2026 | HGH 191AA (Somatropin) | 6.0 A | 5mg | 4.4mg | -11.7% | 99.75% | 53sdkh | Lab C | Public |
| 9 Jan 2026 | Retatrutide Raw | 7.7 A | 1g | 0.9g | -13.2% | 97.51% | 8l2k2s | Lab A | Public |
| 7 Jan 2026 | DNP | 4.9 C | 10mg | 9.4mg | -6.0% | 95.13% | 28j5sl | Lab F | Community |
| 7 Jan 2026 | P21 | 6.0 A | 2mg | 2.2mg | +8.4% | 95.94% | qu07f1 | Lab D | Community |
| 7 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 9.2 A | 5mg | 5.6mg | +11.2% | 96.06% | hpe4bp | Lab G | Community |
| 6 Jan 2026 | IGF-1 LR3 | 6.3 A | 20mg | 22.2mg | +10.9% | 97.53% | p1utzz | Lab G | Public |
| 6 Jan 2026 | N-Acetyl Epitalon Amidate | 5.4 B | 10mg | 9.5mg | -4.6% | 98.78% | fhsn84 | Lab F | Community |
| 6 Jan 2026 | Retatrutide Raw | 5.5 B | 500g | 496.3g | -0.7% | 98.06% | 8ir02y | Lab B | Public |
| 6 Jan 2026 | Vesugen | 9.1 A | 20mg | 17.1mg | -14.7% | 98.71% | dlwc97 | Lab A | Community |
| 29 Dec 2025 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 8.2 A | 100g | 123.2g | +23.2% | 98.66% | tmy7go | Lab F | Public |
| 29 Dec 2025 | Boldenone Undecylenate (EQ) Raw | 8.3 A | 100g | 91.1g | -8.9% | 99.40% | 9vlbfa | Lab F | Public |
| 29 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 5.5 B | 20mg | 18.8mg | -6.2% | 97.21% | 975bf9 | Lab C | Public |
| 29 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.1 A | 5mg | 5.2mg | +3.9% | 98.35% | 5zmnzr | Lab A | Community |
| 29 Dec 2025 | Hyaluronic acid | 6.4 A | 20mg | 20.0mg | -0.1% | 97.74% | 7yokju | Lab A | Community |
| 29 Dec 2025 | IGF-1 LR3 | 5.1 B | 2mg | 1.9mg | -2.5% | 99.33% | ft9bs8 | Lab B | Public |
| 29 Dec 2025 | P21 | 5.8 B | 2mg | 1.8mg | -12.4% | 99.54% | p0t04z | Lab G | Public |
| 29 Dec 2025 | Vesugen | 6.5 A | 50mg | 56.1mg | +12.3% | 95.41% | as3wor | Lab B | Community |
| 12 Dec 2025 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 5.8 B | 500g | 575.8g | +15.2% | 95.19% | 51yu39 | Lab F | Public |
| 12 Dec 2025 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 6.6 A | 10g | 12.5g | +24.8% | 97.10% | 6aycr8 | Lab C | Community |
| 12 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.8 A | 5mg | 5.0mg | -0.5% | 95.41% | sdctho | Lab G | Community |
| 12 Dec 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 8.2 A | 10g | 12.1g | +20.6% | 96.05% | 2r6j78 | Lab G | Community |
| 12 Dec 2025 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 7.1 A | 5g | 6.0g | +19.4% | 95.35% | fsdj6s | Lab D | Community |
| 12 Dec 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.3 A | 2mg | 1.9mg | -6.1% | 98.54% | 7le8xs | Lab F | Community |
| 6 Dec 2025 | Retatrutide | 7.4 A | 5mg | 5.07mg | +1.4% | 99.67% | (no batch ID) | Lab E | Public |
| 6 Dec 2025 | Retatrutide | 8.0 A | 20mg | 20.5mg | +2.5% | 99.95% | (no batch ID) | Lab E | Public |
| 6 Dec 2025 | Retatrutide | 8.0 A | 10mg | 10.4mg | +4.0% | 99.95% | (no batch ID) | Lab E | Public |
| 5 Dec 2025 | Alprostadil | 7.0 A | 15mg | 15.0mg | +0.0% | 98.96% | ayx0rd | Lab A | Community |
| 5 Dec 2025 | DNP | 6.4 A | 20mg | 20.6mg | +2.9% | 95.35% | 01s5w4 | Lab A | Community |
| 5 Dec 2025 | Nandrolone Decanoate (Deca) Raw | 9.0 A | 100g | 88.6g | -11.4% | 99.35% | 62i1hq | Lab A | Public |
| 23 Nov 2025 | 17a-Methyl-1-Testosterone | 8.2 A | 50mg | 48.1mg | -3.8% | 98.12% | r8alk7 | Lab D | Community |
| 23 Nov 2025 | BPC 500mcg + TB500 500mcg Blend Oral | 6.5 A | 20mg | 17.9mg | -10.6% | 95.33% | jqe5ji | Lab A | Community |
| 23 Nov 2025 | DNP | 5.6 B | 10mg | 9.6mg | -4.2% | 98.72% | y77evo | Lab C | Public |
| 23 Nov 2025 | N-Acetyl Epitalon Amidate | 5.5 B | 20mg | 23.2mg | +15.8% | 98.70% | bubzyw | Lab D | Community |
| 23 Nov 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 7.1 A | 1g | 0.9g | -13.2% | 95.56% | assvnm | Lab F | Public |
| 23 Nov 2025 | Retatrutide Raw | 6.8 A | 10g | 11.1g | +11.2% | 99.30% | 796fom | Lab C | Public |
| 17 Nov 2025 | BPC 500mcg + TB500 500mcg Blend Oral | 7.7 A | 20mg | 21.1mg | +5.7% | 99.10% | 7vph6o | Lab A | Community |
| 17 Nov 2025 | HGH 191AA (Somatropin) | 7.1 A | 2mg | 1.9mg | -4.0% | 96.78% | c2ct7g | Lab F | Public |
| 17 Nov 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 7.7 A | 100g | 98.2g | -1.8% | 98.24% | 9dg9yv | Lab E | Public |
| 14 Nov 2025 | 17a-Methyl-1-Testosterone | 6.5 A | 20mg | 20.7mg | +3.3% | 96.01% | ou7z5y | Lab C | Public |
| 14 Nov 2025 | Boldenone Undecylenate (EQ) Raw | 9.2 A | 100g | 94.7g | -5.3% | 95.35% | x1xmm7 | Lab E | Public |
| 14 Nov 2025 | BPC 500mcg + TB500 500mcg Blend Oral | 5.1 B | 50mg | 55.4mg | +10.8% | 98.83% | vg00jj | Lab D | Public |
| 14 Nov 2025 | Vilon | 8.0 A | 30mg | 32.1mg | +6.9% | 95.39% | c6icpt | Lab F | Community |
| 5 Nov 2025 | Cerebrolysin | 5.5 B | 15mg | 13.0mg | -13.1% | 97.71% | yqwnmf | Lab E | Community |
| 5 Nov 2025 | Ivermectin | 4.0 C | 25mg | 21.4mg | -14.5% | 96.92% | ublqum | Lab F | Public |
| 5 Nov 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.8 A | 10mg | 9.7mg | -2.5% | 99.42% | g0tso2 | Lab D | Community |
| 4 Nov 2025 | 17a-Methyl-1-Testosterone | 9.1 A | 20mg | 20.4mg | +2.2% | 96.95% | 5j6q4c | Lab B | Community |
| 4 Nov 2025 | 4-Anilinopiperidine CAS 99918-43-1 | 4.9 C | 10g | 11.4g | +14.4% | 96.81% | 3inw07 | Lab F | Community |
| 4 Nov 2025 | Cerebrolysin | 6.2 A | 2mg | 2.5mg | +25.0% | 99.91% | h6v1iq | Lab D | Public |
| 4 Nov 2025 | GHRP-2 Acetate | 9.2 A | 15mg | 14.7mg | -1.7% | 98.39% | tjqqll | Lab B | Public |